Role of PET/CT in Treatment Planning for Head and Neck Cancer Patients Undergoing Definitive Radiotherapy

Basit Öğe Kaydı
dc.contributor.authorArslan, Sonay
dc.contributor.authorAbakay, Candan Demiroz
dc.contributor.authorSen, Feyza
dc.contributor.authorAltay, Ali
dc.contributor.authorAkpinar, Tayyar
dc.contributor.authorEkinci, Ahmet Siyar
dc.contributor.authorEsbah, Onur
dc.date.accessioned2024-04-24T17:28:19Z
dc.date.available2024-04-24T17:28:19Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: In this study, we aimed to investigate the benefits of 18F-deoxyglucose positron emission tomography/computed tomography (FGD-PET/CT) imaging for staging and radiotherapy planning in patients with head and neck cancer undergoing definitive radiotherapy. Materials and Methods: Thirty-seven head and neck cancer patients who had undergone definitive radiotherapy and PET/CT at the Uludag University Medical Faculty Department of Radiation Oncology were investigated in order to determine the role of PET/CT in staging and radiotherapy planning. Results: The median age of this patient group of 32 males and 5 females was 57 years (13-84years). The stage remained the same in 18 cases, decreased in 5 cases and increased in 14 cases with PET/CT imaging. Total gross tumor volume (GTV) determined by CT (GTVCT-Total) was increased in 32 cases (86.5%) when compared to total GTV determined by PET/CT (GTVPET/CT-Total). The GTV of the primary tumor determined by PET/CT (GTVPET/CT) was larger in 3 cases and smaller in 34 cases compared to that determined by CT (GTVCT). The GTV of lymph nodes determined by PET/CT (GTVLNPET/CT) was larger in 20 cases (54%) and smaller in 12 cases (32.5%) when compared to GTV values determined by CT (GTVLNCT). No pathological lymph nodes were observed in the remaining five cases with both CT and PET/CT. Conclusions: We can conclude that PET/CT can significantly affect both pretreatment staging and assessed target tumor volume in patients with head and neck cancer. We therefore recommend examining such cases with PEC/CT before treatment.en_US
dc.identifier.doi10.7314/APJCP.2014.15.24.10899
dc.identifier.endpage10903en_US
dc.identifier.issn1513-7368
dc.identifier.issue24en_US
dc.identifier.pmid25605198
dc.identifier.startpage10899en_US
dc.identifier.urihttps://doi.org/10.7314/APJCP.2014.15.24.10899
dc.identifier.urihttps://hdl.handle.net/11468/20398
dc.identifier.volume15en_US
dc.identifier.wosWOS:000351058900060
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherAsian Pacific Organization Cancer Preventionen_US
dc.relation.ispartofAsian Pacific Journal of Cancer Prevention
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHead And Neck Canceren_US
dc.subjectPet-Cten_US
dc.subjectRadiotherapyen_US
dc.titleRole of PET/CT in Treatment Planning for Head and Neck Cancer Patients Undergoing Definitive Radiotherapyen_US
dc.titleRole of PET/CT in Treatment Planning for Head and Neck Cancer Patients Undergoing Definitive Radiotherapy
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu